EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rituximab is the way forward for managing Multiple Sclerosis (MS) in Sri Lanka

Praveena Jayasena, Dharmasiri Hirantha Hettige, Saman B. Gunatilake

Sri Lanka Journal of Neurology · 2023

DOI: 10.4038/sljon.v10i2.159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sri Lanka Journal of Neurology, 2023. Verfasst von Praveena Jayasena und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

No abstract available

Zitieren

APA

Jayasena, P., Hettige, D. H., & Gunatilake, S. B. (2023). Rituximab is the way forward for managing Multiple Sclerosis (MS) in Sri Lanka. Sri Lanka Journal of Neurology. https://doi.org/10.4038/sljon.v10i2.159

Vancouver

Jayasena P, Hettige DH, Gunatilake SB. Rituximab is the way forward for managing Multiple Sclerosis (MS) in Sri Lanka. Sri Lanka Journal of Neurology. 2023. doi:10.4038/sljon.v10i2.159

BibTeX
@article{Jayasena2023,
  author = {Jayasena, Praveena and Hettige, Dharmasiri Hirantha and Gunatilake, Saman B.},
  title = {Rituximab is the way forward for managing Multiple Sclerosis (MS) in Sri Lanka},
  journal = {Sri Lanka Journal of Neurology},
  year = {2023},
  doi = {10.4038/sljon.v10i2.159}
}
Kostenlos starten →